ARTICLE | Clinical News
MRX-I: Phase II started
January 6, 2014 8:00 AM UTC
On Dec. 19, 2013, MicuRx said it began a double-blind, Chinese Phase II trial to compare 600 and 800 mg oral MRX-I vs. linezolid in about 200 patients. In 2012, MicuRx and Shanghai Zhangjiang Biomedic...